Eli Lilly claims double crown in pharma R&D rankings
Indiana drugmaker leads both innovation and invention indices for first time as Chinese groups enter the global elite
Indiana drugmaker leads both innovation and invention indices for first time as Chinese groups enter the global elite
French pharma group backs Alpha-1 detection initiative and expands Pompe disease collaboration
Kazakhstan has approved an investment agreement underpinning a 42.5bn tenge (around $80mn) pharmaceutical production complex in the central region of Karaganda, in the latest step of a state-driven campaign to reduce the country's relianceā¦
Takeda Pharmaceutical (TAK) plans to eliminate around 4,500 jobs in fiscal year 2026 as part of a restructuring programme aimed at centralising corporate functions and reducing costs, the Japanese drugmaker said on Wednesday.
Milestone Pharmaceuticals, the dual-listed Canadian-US cardiovascular biotech, reported early commercial momentum for its newly launched nasal-spray heart rhythm therapy and confirmed the start of a late-stage trial in a second, largerā¦
AstraZeneca has announced a £300 million investment in the UK, marking a reversal after previously pausing major projects.
Researchers at the University of WisconsināMadison have developed a method to simplify the formation of carbonānitrogen (CāN) bonds, a fundamental step in producing amines widely used in pharmaceuticals, agrochemicals and advancedā¦
The global market for branded generics is expanding rapidly, reflecting mounting pressure on healthcare systems to contain costs while maintaining patient confidence in treatment quality.
South Korea has consolidated its position as a leading player in pharmaceutical innovation, ranking third globally for drug development pipelines in 2026, behind only the US and China, according to industry data.
Pharmacies warn of supply constraints as freight costs double and petrochemical inputs tighten
AI-integrated facility near Research Triangle Park marks group's largest ever capital outlay
Improved Pharma, the West Lafayette-based pharmaceutical research and consulting group, will present new work on detecting crystalline impurities in amorphous drug formulations at the Spring Pharmaceutical Synchrotron-XRPD Workshop inā¦